Showing results (181-190 of 281) with videos related to

Sort By:
Pageof 29
Journal of Cardiac Failure|September 25, 1999
Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme InvestigatorsK Swedberg, M Pfeffer, C Granger, et al.
European Journal of Heart Failure|June 12, 2003
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programmeJ McMurray, J Ostergren, M Pfeffer, et al.
Lancet (London, England)|September 2, 2008
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial, S Yusuf, K Teo, et al.
European Heart Journal|November 7, 2002
Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromesJ W Eikelboom, J I Weitz, A Budaj, et al.
Diabetologia|August 2, 2005
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysisH C Gerstein, J Pogue, J F E Mann, et al.
Lancet (London, England)|June 13, 2006
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial, S Connolly, J Pogue, et al.
Circulation|August 2, 2001
Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation StudyG R Dagenais, S Yusuf, M G Bourassa, et al.
Lancet (London, England)|October 13, 2001
Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP)S S Anand, S Yusuf, R Jacobs, et al.
Diabetologia|April 8, 2010
Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetesL de Koning, H C Gerstein, J Bosch, et al.
Circulation|August 15, 1996
Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD InvestigatorsC R Benedict, B Shelton, D E Johnstone, et al.
Pageof 29